Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01)

The purpose of this funding opportunity is to incorporate social outcomes and cost effectiveness into the FDA's existing model and policy analysis tool. The goal is to provide more holistic insight into the opioid crisis and enhance decision makers' ability to propose and consider policy options. The work will require the integration of new structural components, new data, and new analyses into the model. The FDA is looking for applicants who can collect information about the costs, social outcomes, and other details associated with potential policies. Key aspects of the job include: • Incorporating social outcomes and cost effectiveness into the FDA's existing model • Collecting information about the costs, social outcomes, and other details associated with potential policies • Integrating new structural components, new data, and new analyses into the model • Enhancing decision makers' ability to propose and consider policy options • Providing more holistic insight into the opioid crisis